On May 28, 2019, Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQB:KHRNF) closed its previously announced bought deal short form prospectus offering of common shares, including the exercise in full of the over-allotment option

On July 17, 2018, Scythian Biosciences Corp. (TSXV: SCYB) (Frankfurt: 9SB) (OTC – Nasdaq Intl: SCCYF) announced that it had entered into a strategic deal with Aphria Inc. (TSX: APH) for Aphria to acquire Scythian's Latin American and Caribbean assets.